bearish
Short Selling Viability Assessment on Celltrion After KOSPI 200 Inclusion
266 Views03 Mar 2018 01:24
Another wonderful day for Celltrion Inc (068270 KS) shareholders, but not a pleasant day for Celltrion short sellers. The shares had a 0.57% gain...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
- Celltrion Holdings' ₩200bil CB with Celltrion Healthcare as Pledged Article - Questions to Ask11 Mar 2018
- ION's Celltrion Block Deals - Summary & Impacts07 Mar 2018
- Celltrion & Celltrion Healthcare Placement - Spread Should Narrow as Inclusion Draws Closer06 Mar 2018
- Short Selling Viability Assessment on Celltrion After KOSPI 200 Inclusion03 Mar 2018
- Celltrion's Mar 8 KOSPI 200 Inclusion Event Update28 Feb 2018
- KOSDAQ 150 Rebalancing & Celltrion Short Selling During Feb 7-809 Feb 2018
- Impact Analysis of Celltrion's KOSPI Move on KOSPI 200 and KOSDAQ 15030 Jan 2018
x